Bin Xu Selected Research

Castration

11/2023	Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL-17 signaling pathway gene LCN2 in castration-resistant prostate cancer.
1/2023	Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer.
1/2022	Tumor microenvironment pH-responsive pentagonal gold prism-based nanoplatform for multimodal imaging and combined therapy of castration-resistant prostate cancer.
1/2021	The Role of Androgen Receptor Splicing Variant 7 in Predicting the Prognosis of Metastatic Castration-Resistant Prostate Cancer: Systematic Review and Meta-Analysis.
1/2020	CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer.
1/2020	LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
12/2019	LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P.
1/2019	MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
1/2018	Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo.
11/2017	Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bin Xu Research Topics

Disease

350	Neoplasms (Cancer) 05/2024 - 11/2002
76	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 06/2009
74	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2002
62	Infections 01/2024 - 06/2003
46	Carcinoma (Carcinomatosis) 05/2024 - 01/2003
43	Inflammation (Inflammations) 01/2024 - 01/2013
41	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 11/2002
38	Breast Neoplasms (Breast Cancer) 12/2024 - 10/2006
35	Obesity 04/2024 - 05/2005
29	Carcinogenesis 01/2023 - 01/2011
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2014
26	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2010
24	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 12/2015
23	Body Weight (Weight, Body) 04/2024 - 01/2010
23	Pain (Aches) 11/2023 - 06/2008
22	Wounds and Injuries (Trauma) 12/2022 - 01/2014
20	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2009
19	Stomach Neoplasms (Stomach Cancer) 01/2023 - 05/2006
18	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2010
17	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2009
17	Lung Neoplasms (Lung Cancer) 06/2023 - 11/2012
17	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2011
16	Disease Progression 05/2024 - 06/2008
15	Fibrosis (Cirrhosis) 05/2023 - 04/2002
15	COVID-19 01/2023 - 01/2020
14	Mitochondrial Diseases (Mitochondrial Disease) 03/2023 - 01/2014
14	Melanoma (Melanoma, Malignant) 01/2023 - 04/2011
14	Glioma (Gliomas) 01/2023 - 10/2014
14	Hemorrhage 09/2022 - 03/2003
13	Insulin Resistance 01/2024 - 07/2009
12	Adenocarcinoma of Lung 11/2023 - 11/2011
11	Stroke (Strokes) 03/2024 - 11/2015
11	Hypoxia (Hypoxemia) 03/2024 - 10/2008
11	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2017
11	Hypertension (High Blood Pressure) 01/2023 - 01/2016
11	Adenocarcinoma 01/2023 - 03/2009
10	Constipation 12/2023 - 03/2014
10	Diabetes Mellitus 12/2022 - 07/2004
10	Ischemia 05/2021 - 10/2003
10	Schizophrenia (Dementia Praecox) 12/2019 - 10/2005
9	Spontaneous Abortion (Miscarriage) 01/2024 - 09/2013
9	Atrial Fibrillation 12/2023 - 09/2011
9	Neuroinflammatory Diseases 01/2023 - 07/2016
9	Ovarian Neoplasms (Ovarian Cancer) 06/2022 - 06/2012
9	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2013

Drug/Important Bio-Agent (IBA)

121	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2002
92	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2009
48	MicroRNAs (MicroRNA)IBA 03/2023 - 04/2010
42	Messenger RNA (mRNA)IBA 11/2023 - 11/2002
36	CytokinesIBA 11/2023 - 04/2002
32	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2005
32	Therapeutic UsesIBA 01/2023 - 02/2004
29	Long Noncoding RNAIBA 02/2024 - 09/2016
24	AntigensIBA 08/2023 - 06/2009
21	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 07/2009
20	Peptides (Polypeptides)IBA 05/2024 - 01/2014
17	VaccinesIBA 02/2023 - 01/2006
16	EnzymesIBA 01/2024 - 07/2010
16	Circular RNAIBA 10/2023 - 01/2019
16	Interleukin-6 (Interleukin 6)IBA 09/2023 - 04/2011
16	Transcription Factors (Transcription Factor)IBA 07/2023 - 04/2011
15	LipidsIBA 04/2024 - 07/2008
15	CholesterolIBA 09/2022 - 06/2011
15	AndrogensIBA 01/2020 - 06/2009
14	Triglycerides (Triacylglycerol)IBA 05/2024 - 01/2014
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 02/2004
14	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2006
14	Phosphotransferases (Kinase)IBA 10/2023 - 03/2009
12	Blood Glucose (Blood Sugar)IBA 04/2024 - 07/2009
12	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2018
12	Small Interfering RNA (siRNA)IBA 12/2023 - 07/2014
12	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2015
12	ManganeseIBA 08/2023 - 12/2016
12	Insulin (Novolin)FDA Link 09/2022 - 06/2004
11	Sirtuin 1IBA 04/2024 - 01/2012
11	C-Reactive ProteinIBA 09/2023 - 01/2018
10	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2024 - 03/2009
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 10/2003
10	ChromatinIBA 11/2023 - 10/2008
10	LigandsIBA 01/2023 - 10/2005
9	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2013
9	Interleukin-10 (Interleukin 10)IBA 09/2023 - 04/2003
9	AntibodiesIBA 05/2023 - 06/2011
9	oxidized low density lipoproteinIBA 09/2022 - 01/2014
9	Lysine (L-Lysine)FDA Link 01/2022 - 04/2011
9	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 07/2006
9	InterleukinsIBA 07/2020 - 04/2003

Therapy/Procedure

141	Therapeutics 04/2024 - 05/2008
48	Drug Therapy (Chemotherapy) 05/2024 - 05/2006
36	Immunotherapy 04/2024 - 01/2014
28	Electroacupuncture 04/2024 - 05/2005
20	Length of Stay 01/2024 - 12/2012
20	Aftercare (After-Treatment) 09/2022 - 12/2008
18	Radiotherapy 03/2023 - 01/2003
17	Castration 11/2023 - 08/2012
12	Nephrectomy 02/2024 - 01/2015
12	Hepatectomy 05/2023 - 01/2004
11	Lasers (Laser) 05/2024 - 09/2012
11	Acupuncture Points (Acupuncture Point) 04/2024 - 12/2010
11	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2010